Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2005-12-23

Original market date: See footnote 1

2001-02-27

Product name:

SANDOZ ORPHENADRINE

DIN:

02243559 Electronic product monograph is not available

Company: 

SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada  J4B 1E6

Class: 

Human

Dosage form(s):

Tablet (Extended-Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

OTC  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

12:20.92   MISCELLANEOUS SKELETAL MUSCLE RELAXANTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

M03BC01  ORPHENADRINE (CITRATE)

Active ingredient group (AIG) number:See footnote 5

0102078001

List of active ingredient(s)
Active ingredient(s) Strength
ORPHENADRINE CITRATE 100 MG

Application information

Related information

Contact us

Version 3.9.0
Date modified: